These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 15953199)
1. Selamectin is a potent substrate and inhibitor of human and canine P-glycoprotein. Griffin J; Fletcher N; Clemence R; Blanchflower S; Brayden DJ J Vet Pharmacol Ther; 2005 Jun; 28(3):257-65. PubMed ID: 15953199 [TBL] [Abstract][Full Text] [Related]
2. Avermectin transepithelial transport in MDR1- and MRP-transfected canine kidney monolayers. Brayden DJ; Griffin J Vet Res Commun; 2008 Jan; 32(1):93-106. PubMed ID: 17578674 [TBL] [Abstract][Full Text] [Related]
3. Functional assessment of multiple P-glycoprotein (P-gp) probe substrates: influence of cell line and modulator concentration on P-gp activity. Taub ME; Podila L; Ely D; Almeida I Drug Metab Dispos; 2005 Nov; 33(11):1679-87. PubMed ID: 16093365 [TBL] [Abstract][Full Text] [Related]
4. P-glycoprotein (MDR1) functional activity in human alveolar epithelial cell monolayers. Endter S; Becker U; Daum N; Huwer H; Lehr CM; Gumbleton M; Ehrhardt C Cell Tissue Res; 2007 Apr; 328(1):77-84. PubMed ID: 17165089 [TBL] [Abstract][Full Text] [Related]
5. The potential inhibitory effect of antiparasitic drugs and natural products on P-glycoprotein mediated efflux. Hayeshi R; Masimirembwa C; Mukanganyama S; Ungell AL Eur J Pharm Sci; 2006 Sep; 29(1):70-81. PubMed ID: 16846720 [TBL] [Abstract][Full Text] [Related]
6. Interaction of macrocyclic lactones with P-glycoprotein: structure-affinity relationship. Lespine A; Martin S; Dupuy J; Roulet A; Pineau T; Orlowski S; Alvinerie M Eur J Pharm Sci; 2007 Jan; 30(1):84-94. PubMed ID: 17134887 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic interaction of the antiparasitic agents ivermectin and spinosad in dogs. Dunn ST; Hedges L; Sampson KE; Lai Y; Mahabir S; Balogh L; Locuson CW Drug Metab Dispos; 2011 May; 39(5):789-95. PubMed ID: 21321059 [TBL] [Abstract][Full Text] [Related]
8. Brain penetration of ivermectin and selamectin in mdr1a,b P-glycoprotein- and bcrp- deficient knockout mice. Geyer J; Gavrilova O; Petzinger E J Vet Pharmacol Ther; 2009 Feb; 32(1):87-96. PubMed ID: 19161460 [TBL] [Abstract][Full Text] [Related]
9. P-glycoprotein interfering agents potentiate ivermectin susceptibility in ivermectin sensitive and resistant isolates of Teladorsagia circumcincta and Haemonchus contortus. Bartley DJ; McAllister H; Bartley Y; Dupuy J; Ménez C; Alvinerie M; Jackson F; Lespine A Parasitology; 2009 Aug; 136(9):1081-8. PubMed ID: 19549355 [TBL] [Abstract][Full Text] [Related]
10. Expression levels of human P-glycoprotein in in vitro cell lines: correlation between mRNA and protein levels for P-glycoprotein expressed in cells. Shirasaka Y; Konishi R; Funami N; Kadowaki Y; Nagai Y; Sakaeda T; Yamashita S Biopharm Drug Dispos; 2009 Apr; 30(3):149-52. PubMed ID: 19243013 [TBL] [Abstract][Full Text] [Related]
11. Effect of hr-IL2 treatment on intestinal P-glycoprotein expression and activity in Caco-2 cells. Belliard AM; Tardivel S; Farinotti R; Lacour B; Leroy C J Pharm Pharmacol; 2002 Aug; 54(8):1103-9. PubMed ID: 12195825 [TBL] [Abstract][Full Text] [Related]
12. Characterization of P-glycoprotein inhibition by major cannabinoids from marijuana. Zhu HJ; Wang JS; Markowitz JS; Donovan JL; Gibson BB; Gefroh HA; Devane CL J Pharmacol Exp Ther; 2006 May; 317(2):850-7. PubMed ID: 16439618 [TBL] [Abstract][Full Text] [Related]
13. P-Glycoprotein (P-gp) expressed in a confluent monolayer of hMDR1-MDCKII cells has more than one efflux pathway with cooperative binding sites. Acharya P; Tran TT; Polli JW; Ayrton A; Ellens H; Bentz J Biochemistry; 2006 Dec; 45(51):15505-19. PubMed ID: 17176072 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of P-glycoprotein-mediated transport by terpenoids contained in herbal medicines and natural products. Yoshida N; Koizumi M; Adachi I; Kawakami J Food Chem Toxicol; 2006 Dec; 44(12):2033-9. PubMed ID: 16904803 [TBL] [Abstract][Full Text] [Related]
15. Role of P-glycoprotein in the disposition of macrocyclic lactones: A comparison between ivermectin, eprinomectin, and moxidectin in mice. Kiki-Mvouaka S; Ménez C; Borin C; Lyazrhi F; Foucaud-Vignault M; Dupuy J; Collet X; Alvinerie M; Lespine A Drug Metab Dispos; 2010 Apr; 38(4):573-80. PubMed ID: 20089736 [TBL] [Abstract][Full Text] [Related]
16. Transport characteristics of rutin deca (H-) sulfonate sodium across Caco-2 cell monolayers. He Y; Zeng S J Pharm Pharmacol; 2005 Oct; 57(10):1297-303. PubMed ID: 16259758 [TBL] [Abstract][Full Text] [Related]
17. Comparing therapeutic efficacy between ivermectin, selamectin, and moxidectin in canaries during natural infection with Dermanyssus gallinae. Todisco G; Paoletti B; Giammarino A; Manera M; Sparagano OA; Iorio R; Giannella B; Robbe D Ann N Y Acad Sci; 2008 Dec; 1149():365-7. PubMed ID: 19120251 [TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of fruit extracts on P-glycoprotein-related efflux carriers: an in-vitro screening. Deferme S; Van Gelder J; Augustijns P J Pharm Pharmacol; 2002 Sep; 54(9):1213-9. PubMed ID: 12356275 [TBL] [Abstract][Full Text] [Related]
19. P-glycoprotein-mediated transport of oxytetracycline in the Caco-2 cell model. Schrickx J; Fink-Gremmels J J Vet Pharmacol Ther; 2007 Feb; 30(1):25-31. PubMed ID: 17217397 [TBL] [Abstract][Full Text] [Related]
20. Caco-2 cell methodology and inhibition of the P-glycoprotein transport of digoxin by Aloe vera juice. Djuv A; Nilsen OG Phytother Res; 2008 Dec; 22(12):1623-8. PubMed ID: 19003953 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]